Investigation of the antibacterial activity of a chloroform extract of Ling Zhi or Reishi medicinal mushroom, Ganoderma lucidum (W. Curt.: Fr.) P. Karst. (Aphyllophoromycetideae), from Iran

International Journal of Medicinal Mushrooms

Volumn 10, Issue 4, 2008, Pages 345-349

  Keypour, Somayeh ^a   Riahi, Hossein ^a   Moradali, Mohammad Fata ^b   Rafati, Hassan ^a  

^a SHAHID BEHESHTI UNIVERSITY   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Antibacterial activity; Chloroform extract; Ganoderma lucidum; Medicinal mushrooms; Reishi or Ling Zhi mushroom

Indexed keywords

CHLORAMPHENICOL; CHLOROFORM; ERYTHROMYCIN; GANODERMA LUCIDUM EXTRACT; GENTAMICIN; LIPID; STEROL; TRITERPENOID;

ANALYTIC METHOD; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CONTROLLED STUDY; DRUG ISOLATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FRUITING BODY; GROWTH INHIBITION; IRAN; MEDICINAL MUSHROOM; MINIMUM INHIBITORY CONCENTRATION; MUSHROOM; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

BACILLUS SUBTILIS; BASIDIOMYCOTA; ENTEROCOCCUS; ESCHERICHIA COLI; GANODERMA LUCIDUM; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 53649101629     PISSN: 15219437     EISSN: None     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v10.i4.70     Document Type: Article

References (25)

1. Moradali MF, Mostafavi H, Ghods S, Hedjaroude G-A. Immunomodulating and anticancer agent in realm of macromycetes fungi (macrofungi). Int Immunopharmacol. 2007;7:701-24.
2. Moradali MF, Mostafavi H, Hedjaroude G-A, Sharifi Tehrani A, Abbasi M, Ghods S. Investigation of potential antibacterial properties of methanol extracts from fungus Ganoderma applanatum. Chemotherapy. 2006;52:241-4.
3. Wasser SP. Reishi or Ling Zhi (Ganoderma lucidum). In: Coates PM, Blackman MR, Cragg G, Levine M, Moss J, White J, editors. Encyclopedia of Dietary Supplements. New York: Marcel Dekker; 2005. p. 603-22.
4. Gao Y, Lan J, Dai X, Ye J, Zhou S. A phase I/II study of Ling Zhi Mushroom Ganoderma lucidum (W. Curt.: Fr.) Lloyd (Aphyllophoromycetaceae) extract in patients with type II diabetes mellitus. Int J Med Mushr. 2004;6(1):33-9.
5. Gao Y, Zhou S, Chen G, Dai X, Ye J. A phase I/II study of Ganoderma lucidum (Curt.: Fr.) P. Karst. extract (ganopoly) in patients with advanced cancer. Int J Med Mushr. 2002;4(3):207-14.
6. Eo SK, Kim YS, Lee CK, Han SS. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J Ethnopharmacol. 1999;68:129-36.
7. Yoon SY, Eo SK, Kim YS, Lee CK, Han SS. Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch Pharm Res. 1994;17:438-42.
8. Min BS, Nakamura N, Miyashiro H, Bae KW, Hattori M. Triterpenes from the spore of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull. 1998;46:1607-12.
9. Di X, Chan KKC, Leung HW, Huie CW. Fingerprint profiling of acid hydrolyzates of polysaccharides extracted from the fruiting bodies and spores of Ling Zhi by high-performance thin-layer chromatography. J Chromatogr A. 2003;1018:85-95.
10. Kim HW, Kim BK. Biomedical triterpenoids of Ganoderma lucidum (Curt.: Fr.) P.Karst. (Aphyllophoromycetidae). Int J Med Mushr. 1999;1(2):121-38.
11. Roberts LM. Australian Ganoderma: identification, growth, and antibacterial properties [PhD thesis]. Melbourne (Australia): Swinburne University of Technology; 2004. 271 p.
12. Mizuno T. Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects. Food Rev Int. 1995;11(1):151-66.
13. Moradali MF, Hedjaroude GHA, Mostafavi H, Abbasi M, Ghods SH, Sarifi Tehrani A. The genus Ganoderma (Basidiomycota) in Iran. Mycotaxon. 2007;99:251-69.
14. Lovy A, Knowles B, Labbe R, Nolan L. Activity of edible mushrooms against the growth of human T4 leukemic cancer cells, HeLa cervical cancer cells, and Plasmodium falciparum. J Herb Spice Med Plant. 1999;6:49-57.
15. Kim BK, Cho HY, Kim JS, Kim HW, Choi EC. Studies on constituents of higher fungi of Korea (LXVIII). Antitumor components of the cultured mycelia of G. lucidum. Korean J Pharmacol. 1993;24:203-12.
16. Rofuli BN, Cruz AGV, Medalla AP, Buenavista MTS. Antimicrobial and antagonistic properties of Ganoderma lucidum (W. Curt: Fr.) Lloyd. Int J Med Mushr. 2005;7.
17. Ofodile LN, Uma NU, Kokubun T, Grayer RJ, Ogundipe OT, Simmonds SJ. Antimicrobial activity of some Ganoderma species from Nigeria. Phytother Res. 2005;19:310-3.
18. NCCLS (National Committee for Clinical Laboratory Standards). Performance Standards for Antimicrobial Susceptibility Testing, 9th International Supplement. Wayne (PA): NCCLS; 1999. p. M100-S9.
19. Liebermann C. Über das oxychinoferben. Berichte. 1885;18:1803-9.
20. Whitby GS. Some new reactions for the detection of sterols. Biochem J. 1923;17:5-12.
21. Nöller CR, Smith RA, Harris GR, Walker JM. Saponins and sapogenins. Some color reactions of triterpenoid sapogenins. J Am Chem Soc. 1942;64:3047.
22. Smania A, Delle Mondache F, Smania EF, Cuneo RS. Antibacterial activity of steroidal compounds from Ganoderma applanatum (Pers.) Pat. (Aphyllophoromycetideae) fruit body. Int J Med Mushr. 1999;1:325-30.
23. Yihuai G, Zhou S, Huang M, Xu A. Antibacterial and antiviral value of the genus Ganoderma P. Karst. species (Aphyllophoromycetideae): a review. Int J Med Mushr. 2003;5:235-46.
24. Kleinwächter P, Anh N, Kiet TT, Schlegel B, Dahse HM, Hartl A, Grafe U. Colossolactones, new triterpenoid metabolites from a Vietnamese mushroom Ganoderma colossum. J Nat Prod. 2001;64:236-9.
25. Sheena N, Ajith TA, Mathew T, Janardhanan KK. Antibacterial activity of three macrofungi, Ganoderma lucidum, Navesporus floccose and Phellinus rimosus occurring in South India. Pharm Biol. 2003;41:564-7.